Late recurrence in melanoma: clinical implications of lost dormancy.
about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionPhylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.Final trial report of sentinel-node biopsy versus nodal observation in melanoma.Protracted dormancy of pre-leukemic stem cells.Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma SurvivorsOngoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report.Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to PrognosisEndobronchial melanoma metastasis 40 years after the excision of the primary cutaneous tumor: A case report.A slow-cycling subpopulation of melanoma cells with highly invasive properties.Genomic analysis of melanoma evolution following a 30-year disease-free interval.New insights into tumor dormancy: Targeting DNA repair pathways.Trans rectus sheath extra-peritoneal procedure (TREPP) for inguinal hernia: the first 1,000 patients.Skin surgery, an evidence-based update: meeting report.Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.Recurrence of Melanoma After Initial Treatment: Diagnostic Performance of FDG PET in Posttreatment Surveillance
P2860
Q21195742-B02AAE69-EDCC-42D7-A50C-D6225265B258Q30403025-507B9076-F91B-408F-B627-7AE065CDE73CQ33760173-B11A844B-7F6A-4A8A-A091-FEDAA419E929Q36045125-43F8B4EF-10F9-41A2-B1E0-D397EE85003CQ37239624-15329661-B8C7-4A3B-B5D7-29CD0FD621FCQ37642191-29B17E1A-003B-48A6-9EF2-54E172BCD75BQ38619615-654F6004-319E-4031-874D-11EB75F5CCEAQ39749642-40381148-5A7D-49F3-BBE1-A0DFF0CBA04EQ41384530-472D7C14-1129-4A9A-81D5-62DACFF2066FQ41524019-830A959B-3634-49A3-9125-E8756A667233Q41996634-66AFC6FF-6634-4A54-B02F-93CA3951BA59Q42672753-2D4300F8-4926-4A25-9EB0-E1EBEE7A4482Q43227475-14820D5E-1E3A-4DA0-AE92-64CD4201852AQ47914454-81F11445-3940-4209-913E-C9D0697D56B6Q48175321-94393C44-2ECA-4411-B9B2-2C878B7D9809Q48479762-51EE0BB4-CF20-4900-BC6C-0ADD428401A9Q57820494-A4377C99-DA23-4680-9DAE-F041979AD938
P2860
Late recurrence in melanoma: clinical implications of lost dormancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Late recurrence in melanoma: clinical implications of lost dormancy.
@en
Late recurrence in melanoma: clinical implications of lost dormancy.
@nl
type
label
Late recurrence in melanoma: clinical implications of lost dormancy.
@en
Late recurrence in melanoma: clinical implications of lost dormancy.
@nl
prefLabel
Late recurrence in melanoma: clinical implications of lost dormancy.
@en
Late recurrence in melanoma: clinical implications of lost dormancy.
@nl
P2093
P2860
P1476
Late recurrence in melanoma: clinical implications of lost dormancy.
@en
P2093
Donald L Morton
Mark B Faries
Shawn Steen
P2860
P304
27-34; discussion 34-6
P356
10.1016/J.JAMCOLLSURG.2013.03.007
P577
2013-05-03T00:00:00Z